Related Experiment Video
Updated: Feb 22, 2026

10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
15.4K
2016 Pediatric Annual Report: Almost a 10.
Bulletin of the American College of Surgeons
|September 20, 2017
Summary
The International Classification of Diseases, Tenth Revision (ICD-10) offers improved trauma coding. It features expanded injury codes and greater specificity for better condition description and laterality assignment.
Area of Science:
- Medical coding systems
- Health informatics
- Trauma registries
Background:
- The International Classification of Diseases, Ninth Revision (ICD-9) has limitations in specificity for trauma coding.
- Accurate and detailed coding is crucial for trauma research, patient care, and resource allocation.
Purpose of the Study:
- To highlight the advantages of the International Classification of Diseases, Tenth Revision (ICD-10) for trauma coding compared to its predecessor.
- To detail specific improvements in ICD-10 relevant to injury coding.
Main Methods:
- Comparative analysis of coding structures between ICD-9 and ICD-10.
- Review of specific ICD-10 features related to trauma and injury coding.
Main Results:
- ICD-10 includes expanded injury codes, offering greater detail.
- Combination codes streamline the description of conditions, reducing the number of necessary codes.
- The addition of two characters and subclassifications enhances specificity, including laterality.
Conclusions:
- ICD-10 provides significant advancements for trauma coding.
- Increased specificity and efficiency in ICD-10 coding support improved data quality for trauma research and clinical practice.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
353
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Distribution
356
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
Pharmacokinetics in Pediatric Patients: Drug Excretion
302
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Pharmacokinetics in Pediatric Patients: Drug Metabolism
276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Standards of Care II
1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Drug Dosing: Infants and Children
371
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
371

